Dr. Rajan Goel

Pharmaceutical industry researcher with proven track record in drug discovery and development, drug repurposing and translational research. Subject matter expert for the evaluation, development and due diligence of novel healthcare products and therapeutics.Versatile experience of leading team of scientists responsible for pre-clinical modeling of human disease including ex-vivo, in- vivo (animal models) efficacy, target-engagement, biomarkers assessment and safety pharmacology across different disease areas.Regulatory documentation to support Ph 1 and Ph 2 clinical development including Investigational New Drug Application (INDA) and related documents.Key contributor to out-licensing of three small molecules (alpha blocker for BPH, MALT1 inhibitor and MEK inhibitor for cancer) to three different global pharma companies. More than eight potential drug candidates entered in advance clinical development stages in India and abroad. Identification of differentiated clinical and potential drug candidates.Experience of working for different therapeutic areas viz. cardiovascular diseases, metabolic disorders, chronic pain, bone metabolism, chronic kidney disease, CNS disorders, oncology, immuno-oncology, autoimmune disorders, inflammation and urological complications.Evaluation, assessment and validation of novel discovery research targets. Exploring unmet medical needs in different therapeutic areas and disease indications.Added experience of working for women healthcare innovation and discovery research.Cross-functional execution of preclinical studies required for drug discovery and development including chemistry, analytical, in-vitro, in-vivo, pharmacodynamics, ADME, safety and clinical teams, enabling drug developmentExtensive experience of leveraging scientific opportunities, cross-functional leadership, strategy planning, implementation, knowledge management, project mentoring, resource optimization, talent identification and nurturing teams to ensure success.Planning and tracking annual budget and capital expenditure for the department and drive processes and systems to adhere to the planned budget.#opentowork #jobapportunity